<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00906126</url>
  </required_header>
  <id_info>
    <org_study_id>122006051</org_study_id>
    <nct_id>NCT00906126</nct_id>
  </id_info>
  <brief_title>Oral Misoprostol for Labor Augmentation: A Pilot Study</brief_title>
  <official_title>Oral Misoprostol for Labor Augmentation: A Dose-Finding Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A phase I, open-label trial to determine a safe dose of oral misoprostol required to augment
      labor in nulliparous women diagnosed with arrest of dilation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>uterine hyperstimulation</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>adequate uterine activity</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>need for oxytocin augmentation</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time from administration of study drug to delivery</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>route of delivery and indications</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal and neonatal infectious morbidity</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neonatal outcomes</measure>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Arrest of Dilation in Labor</condition>
  <arm_group>
    <arm_group_label>Oral Misoprostol 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral misoprostol 25 micrograms every 4 hours for up to two doses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Misoprostol 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral misoprostol 50 micrograms every 4 hours for up to two doses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Misoprostol 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral misoprostol 100 micrograms every 4 hours for up to two doses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Misoprostol 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral Misoprostol 50 micrograms every 2 hours for up to two doses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Misoprostol 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral Misoprostol 75 micrograms every 4 hours for up to two doses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>Oral misoprostol</description>
    <arm_group_label>Oral Misoprostol 1</arm_group_label>
    <arm_group_label>Oral Misoprostol 2</arm_group_label>
    <arm_group_label>Oral Misoprostol 3</arm_group_label>
    <arm_group_label>Oral Misoprostol 4</arm_group_label>
    <arm_group_label>Oral Misoprostol 5</arm_group_label>
    <other_name>Cytotec</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  nulliparous

          -  gestational age of at least 36 weeks

          -  singleton gestation

          -  cephalic presentation

          -  reassuring fetal heart rate

          -  4 cm or greater cervical dilation

          -  ruptured membranes with clear amnionic fluid

          -  intrauterine pressure catheter in place

          -  less than 200 MVU's

        Exclusion Criteria:

          -  non-reassuring fetal heart rate

          -  meconium-stained amnionic fluid

          -  previous uterine incision

          -  maternal fever

          -  pregnancy-induced hypertension or other pregnancy-related complications

          -  known fetal anomalies

          -  placenta previa or unexplained vaginal bleeding

          -  estimated fetal weight of 4,500 grams or greater

          -  evidence of cephalopelvic disproportion

          -  any moderate or severe preexisting disease

          -  contraindication to the use of prostaglandins
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathryn S Villano, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2009</study_first_submitted>
  <study_first_submitted_qc>May 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2009</study_first_posted>
  <last_update_submitted>May 20, 2009</last_update_submitted>
  <last_update_submitted_qc>May 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kathryn Villano, M.D.</name_title>
    <organization>University of Texas Southwestern Medical Center</organization>
  </responsible_party>
  <keyword>oral misoprostol</keyword>
  <keyword>labor augmentation</keyword>
  <keyword>arrest of dilation</keyword>
  <keyword>nulliparous</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

